Cargando…
The role of neo-adjuvant therapy in cholangiocarcinoma: A systematic review
INTRODUCTION: Cholangiocarcinoma (CCA) is the most common malignancy affecting the biliary tree. The only curative treatment is surgical resection, aiming for negative margins (R0). For those who have locally advanced disease, which is borderline resectable, neoadjuvant chemoradiation presents an op...
Autores principales: | Cremen, Sinead, Kelly, Michael E., Gallagher, Tom K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779982/ https://www.ncbi.nlm.nih.gov/pubmed/36568243 http://dx.doi.org/10.3389/fonc.2022.975136 |
Ejemplares similares
-
Current Status of Intensified Neo-Adjuvant Systemic Therapy in Locally Advanced Rectal Cancer
por: Engels, Benedikt, et al.
Publicado: (2012) -
Adjuvant therapy for cholangiocarcinoma after surgery and prognosis factors for cholangiocarcinoma: A single-center retrospective cohort study
por: Sun, Zhongquan, et al.
Publicado: (2023) -
Impact of oncoplasty in increasing breast conservation rates Post neo-adjuvant chemotherapy
por: Koppiker, Chaitanyanand B., et al.
Publicado: (2023) -
Neo–adjuvant hormonal treatment for the undescendent testis – a benefit for the patient?
por: Stein, Raimund
Publicado: (2013) -
Gemcitabine and Cisplatin as Neo-Adjuvant for Cholangiocarcinoma Patients Prior to Liver Transplantation: Case-Series
por: Abdelrahim, Maen, et al.
Publicado: (2022)